Laboratorios Farmaceuticos Rovi's total assets for Q1 2025 were €813.96M, a decrease of -2.17% from the previous quarter. GB:0ILL total liabilities were €214.50M for the fiscal quarter, a -14.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.